TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
SLDB

Solid Biosciences LLC

Healthcare · Biotechnology

8.90$ +0.5% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Solid Biosciences LLC (SLDB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 421 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SLDB
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
185 165 249 231 212 189 344 308 274 233 423 421
148 130 214 198 179 157 313 279 245 205 397 395
49 74 118 96 64 80 211 139 61 60 298 159
143 124 206 190 171 149 307 268 236 188 381 378
40 38 38 38 45 51 49 50 56 53 49 47
16 15 14 15 23 30 29 30 36 33 30 29
2.3 2.3 2.2 2.2 2.8 3.0 3.0 2.9 2.3 2.1 2.2 2.2
1.9 2.0 1.7 2.5 3.5 4.2 6.4 4.7 8.4 3.2 5.6 4.4
144 126 211 193 167 137 294 258 218 180 374 374
-638 -659 -683 -708 -741 -783 -823 -862 -908 -958 -1,015 -1,069
20 29 38 41 41 54 66 94 94 95 110 144

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?